Method 01
Reverse-phase HPLC
C18, 220 nm, gradient elution
Peak area quantifies purity against the principal component. The measured value is printed on the certificate. Never rounded up, never inferred from a supplier label.
Canadian supplier · 39 compounds in stock
Research peptides, documented to the lot.
Every compound we ship is assayed by an independent laboratory and published with its Certificate of Analysis, batch number and test date. Purity you can read, not purity we claim.
≥99%
HPLC purity floor
100%
Lots with published COA
48h
Dispatch from Ontario
01
Third-party tested
Independent lab, every production lot
02
HPLC + MS verified
Purity quantified, identity confirmed
03
Ships from Canada
Ontario facility, tracked, 48h dispatch
04
Discreet packaging
Unbranded outer, no contents listed
01 / Catalog
Compounds in stock
Every listing carries its CAS number, molecular weight and the certificate for the lot currently shipping.
02 / Verification
Two methods, every lot, before anything ships.
Identity is confirmed by mass spectrometry against theoretical molecular weight. Purity is quantified by reverse-phase HPLC. Both reports attach to the lot number printed on your vial.
Method 02
Mass spectrometry
ESI-MS, positive mode
Observed mass is compared to the theoretical molecular weight for the sequence. A lot only ships when observed and theoretical agree within tolerance.
Method 03
Lot traceability
Vial label resolves to certificate
Each vial carries a lot number that resolves to a single certificate in the public library. Nothing is pooled, relabelled or re-lotted after testing.
03 / Documentation
Recent certificates of analysis
The most recent lots released, with their assay reports.
| Compound | Lot | Tested | Method | Purity | Result | Certificate |
|---|---|---|---|---|---|---|
| Retatrutide Double Cartridge | RETA-2607A | 2026-07-08 | HPLC + MS | 99.38% | Pass | On request |
| Tirzepatide Double Cartridge | TIRZ-2607A | 2026-07-08 | HPLC + MS | 99.38% | Pass | On request |
| CJC-1295 no DAC + Ipamorelin | CJC1-2607A | 2026-07-08 | HPLC + MS | 99.67% | Pass | On request |
| KPV + GHK-Cu | KPVG-2607A | 2026-07-08 | HPLC + MS | 99.35% | Pass | On request |
| KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) | KLOW-2607A | 2026-07-08 | HPLC + MS | 99.25% | Pass | On request |
| GLOW (BPC-157 + GHK-Cu + TB-500) | GLOW-2607A | 2026-07-08 | HPLC + MS | 99.19% | Pass | On request |
Questions researchers ask
What we can answer, and what we will not.
Every vial carries a lot number. That number resolves to one certificate in the lab results library, showing the test date, the method and the measured purity. If the numbers on the vial and the certificate do not agree, tell us and we will withdraw the lot.
No. These compounds are supplied for in-vitro laboratory research only. We publish no dosage, administration or reconstitution guidance and we will not answer questions of that kind, whatever the framing.
No card processor sits between you and us, so no card data exists to be leaked. You send the transfer from your own bank, quoting the reference on your order, and we dispatch once it clears.
Lyophilised powder held at -20°C, shipped in an unbranded outer carton with insulation and, where the compound requires it, a cold pack. Tracked, one to three business days across Canada.
Yes. Historical certificates are kept even after a lot sells through. Email the lot number printed on the vial and we will send the report.